BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14648970)

  • 1. [Male breast cancer].
    Medraś M; Szczesny M
    Pol Merkur Lekarski; 2003 Aug; 15(86):111-4. PubMed ID: 14648970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Male breast cancer.
    Hecht JR; Winchester DJ
    Am J Clin Pathol; 1994 Oct; 102(4 Suppl 1):S25-30. PubMed ID: 7942610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
    Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients.
    Cutuli B; Cottu PH; Guastalla JP; Mechin H; Costa A; Jourdan R
    Breast Cancer Res Treat; 2006 Jan; 95(1):55-64. PubMed ID: 16261401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 19. Male breast cancer: aetiology, genetics and clinical management.
    Tischkowitz MD; Hodgson SV; Fentiman IS
    Int J Clin Pract; 2002 Dec; 56(10):750-4. PubMed ID: 12510948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple primary tumors in men with breast cancer diagnoses: a SEER database review.
    Wernberg JA; Yap J; Murekeyisoni C; Mashtare T; Wilding GE; Kulkarni SA
    J Surg Oncol; 2009 Jan; 99(1):16-9. PubMed ID: 18937232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male breast cancer in the veterans affairs population: a comparative analysis.
    Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
    Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of male breast cancer.
    Weiss JR; Moysich KB; Swede H
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):20-6. PubMed ID: 15668471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
    Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
    Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unopposed estrogen therapy and the risk of invasive breast cancer.
    Chen WY; Manson JE; Hankinson SE; Rosner B; Holmes MD; Willett WC; Colditz GA
    Arch Intern Med; 2006 May; 166(9):1027-32. PubMed ID: 16682578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative epidemiology of breast cancer among men and women in the US, 1996 to 2000.
    Goodman MT; Tung KH; Wilkens LR
    Cancer Causes Control; 2006 Mar; 17(2):127-36. PubMed ID: 16425090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer of the male breast.
    Donegan WL
    J Gend Specif Med; 2000; 3(4):55-8. PubMed ID: 11253231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
    Harlan LC; Clegg LX; Abrams J; Stevens JL; Ballard-Barbash R
    J Clin Oncol; 2006 Feb; 24(6):872-7. PubMed ID: 16484696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of prostate cancer by androgens: experimental paradox or clinical reality.
    Algarté-Génin M; Cussenot O; Costa P
    Eur Urol; 2004 Sep; 46(3):285-94; discussion 294-5. PubMed ID: 15306098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.